CardioFocus

CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, and investigating disposable fiber optic catheters for the visualization of cardiac anatomy and the treatment of cardiac arrhythmias.

CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.

CardioFocus headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical, Medical Device sector. The company focuses on Biotechnology and has secured $85.8B in funding across 320 round(s). With a team of 51-100 employees, CardioFocus is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - CardioFocus, raised $30.6M. Discover more about their projects, partnerships, and impact on our platform.